GENFLEET-B (02595) Announces Monthly Securities Movement Update for February 2026

Bulletin Express03-05

GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, stock code: 02595) published its monthly return for the period ended 28 February 2026, detailing the status of both its Hong Kong-listed and unlisted ordinary shares. Company records indicate that there were no changes to the total number of issued H shares and unlisted shares during the reporting month.

The H share count remained at 338,029,020 shares, representing RMB 33.80 million in issued share capital based on a par value of RMB 0.1 per share. Unlisted shares stood at 32,337,610 shares, totaling RMB 3.23 million in issued share capital. The aggregate issued share capital at month-end was RMB 37.04 million. No share repurchases, conversions, or cancellations were reported.

Public float requirements under the relevant Main Board Rules continued to be met, with GenFleet Therapeutics (Shanghai) Inc. maintaining a float threshold of 19.86%. The company confirmed compliance based on publicly available information. No new share options, warrants, or convertible securities were disclosed for February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104829936?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 17:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104829936","market":"hk","top_or_hot":-1,"title":"GENFLEET-B (02595) Announces Monthly Securities Movement Update for February 2026","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, stock code: 02595) published its monthly return for the period ended 28 February 2026, detailing the status of both its Hong Kong-listed and unlisted ordinary shares. Company records indicate that there were no changes to the total number of issued H shares and unlisted shares during the reporting month.</p>\n<p>The H share count remained at 338,029,020 shares, representing RMB 33.80 million in issued share capital based on a par value of RMB 0.1 per share. Unlisted shares stood at 32,337,610 shares, totaling RMB 3.23 million in issued share capital. The aggregate issued share capital at month-end was RMB 37.04 million. No share repurchases, conversions, or cancellations were reported.</p>\n<p>Public float requirements under the relevant Main Board Rules continued to be met, with GenFleet Therapeutics (Shanghai) Inc. maintaining a float threshold of 19.86%. The company confirmed compliance based on publicly available information. No new share options, warrants, or convertible securities were disclosed for February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GENFLEET-B (02595) Announces Monthly Securities Movement Update for February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGENFLEET-B (02595) Announces Monthly Securities Movement Update for February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 17:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, stock code: 02595) published its monthly return for the period ended 28 February 2026, detailing the status of both its Hong Kong-listed and unlisted ordinary shares. Company records indicate that there were no changes to the total number of issued H shares and unlisted shares during the reporting month.</p>\n<p>The H share count remained at 338,029,020 shares, representing RMB 33.80 million in issued share capital based on a par value of RMB 0.1 per share. Unlisted shares stood at 32,337,610 shares, totaling RMB 3.23 million in issued share capital. The aggregate issued share capital at month-end was RMB 37.04 million. No share repurchases, conversions, or cancellations were reported.</p>\n<p>Public float requirements under the relevant Main Board Rules continued to be met, with GenFleet Therapeutics (Shanghai) Inc. maintaining a float threshold of 19.86%. The company confirmed compliance based on publicly available information. No new share options, warrants, or convertible securities were disclosed for February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1104829936","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104829936","pubTimestamp":1772703588,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, stock code: 02595) published its monthly return for the period ended 28 February 2026, detailing the status of both its Hong Kong-listed and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GENFLEET-B(02595)公布2026年2月每月证券变动更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, stock code: 02595) published its monthly return for the period ended 28 February 2026, detailing the status of both its Hong Kong-listed and unlisted ordinary shares. Company records indicate that there were no changes to the total number of issued H shares and unlisted shares during the reporting month.\nThe H share count remained at 338,029,020 shares, representing RMB 33.80 million in issued share capital based on a par value of RMB 0.1 per share. Unlisted shares stood at 32,337,610 shares, totaling RMB 3.23 million in issued share capital. The aggregate issued share capital at month-end was RMB 37.04 million. No share repurchases, conversions, or cancellations were reported.\nPublic float requirements under the relevant Main Board Rules continued to be met, with GenFleet Therapeutics (Shanghai) Inc. maintaining a float threshold of 19.86%. The company confirmed compliance based on publicly available information. No new share options, warrants, or convertible securities were disclosed for February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104829936","isCrawlerRequest":true}